TRANSPLANT RENAL ARTERY STENOSIS: SINGLE CENTER EXPERIENCE


Haras A. B., Yadigar S., Ozdemir P., ÖZER AYDIN Ç., Parmaksiz E., Mese M., ...More

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, vol.83, no.1, pp.55-59, 2020 (ESCI) identifier

Abstract

Objective: Transplant renal artery stenosis (TRAS) and post-transplant arterial hypertension is a treatable cause of allograft dysfunction and graft loss. The risk factors for the development of TRAS include: donor age, prolonged and delayed graft function, cold ischemia time,concomitant CMV infection and surgical technique. Percutaneous transluminal angioplasty (PTA) has proven successful in treating TRAS in 60-90% of cases by providing renal reperfusion. In this study,we evaluated six TRAS cases in our clinic.